AFP and hepatocellular carcinoma: In Italy, HCC patients can be included on the wait list so long as a 5-year survival rate of 50% is expected, and multiple criteria (e.g., Milan criteria, UCSF criteria, TTV criteria, Up-to-7 criteria, French AFP model, etc.)are allowed to be used [107].